January 15, 2022 – Babies who are born with only one functioning heart ventricle must undergo a series of three surgeries to correct the problem. The final surgery establishes Fontan circulation, which reroutes the circulatory system. However, more than half of patients who undergo the procedure don’t live into adulthood. To reduce the negative health effects associated with the Fontan procedure, UCF researchers are developing a self-powered injection jet shunt that uses the heart’s own energy to alleviate the heightened internal pressure caused by the rerouted circulatory system.

February 15, 2022 – Vivalink, a leading provider of digital healthcare solutions, has announced the results of a company survey focused on clinicians’ use of Holter monitors versus mobile cardiac telemetry (MCT).

February 15, 2022 — The American College of Cardiology’s Cardiovascular Summit Virtual (CV Summit) will feature three days of live content on Feb. 17-19, 2022, providing opportunities for the entire CV team to learn from multi-dimensional education courses on CV management and leadership strategies.

February 15, 2022 – A multicenter, retrospective database analysis suggests improved open abdominal aortic aneurysm (AAA) outcomes when surgeon volume is greater than seven cases yearly and performed in hospitals with a 30-day mortality rate less than 5%.

“Open AAA repair has decreased in frequency owing to the increasing adoption of endovascular techniques, prompting concern that the decreased yearly clinical experience will affect operative results,” said senior author Adam Doyle, MD, from the University of Rochester Medical Center.

February 15, 2022 — Vaccine-associated myocarditis shows a similar injury pattern on cardiac MRI compared to other causes of myocarditis, but abnormalities are less severe, according to a new study published in the journal Radiology.

February 15, 2022 – Alkem Laboratories Limited (Alkem), an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University’s Office of Technology Development (OTD) enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease.

February 15, 2022 — Viz.ai and TeleSpecialists, LLC  have entered a strategic partnership that will bring AI-powered stroke care together with leading telestroke neurologists to optimize time to treatment and improve patient outcomes across the United States.

February 15, 2022 — The leaders of three of the nation’s leading cardiology groups – American Heart Association President Donald M. Lloyd-Jones, M.D., Sc.M., FAHA; American College of Cardiology President Dipti Itchhaporia, MD, FACC and Association of Black Cardiologists Michelle A. Albert, MD, MPH – issued the following statement expressing support for the nomination of Robert M. Califf, M.D. as commissioner of the Food and Drug Administration (FDA) and urging a timely Senate confirmation vote:

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices Companies, has announced the launch of EMBOGUARD, a next generation balloon guide catheter to be used in endovascular procedures, including those for patients with acute ischemic stroke.

February 15, 2022 — UC Davis pediatric electrophysiologist

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now